These findings describe associations in a large administrative dataset and do not establish causation
(Many insurers will not typically cover new weight-loss drugs, but may cover the same medication to treat diabetes, the New York Times reported.) The company has protocols in place so that [the GLP-1 drugs] are not utilized for purposes that are other than medical necessity for diabetes-type folks, Gallina said
Fascinatingly, MT-II also modulates metabolism, appetite, and cognition by binding to melanocortin receptors throughout the body
First isolated in the 1970s, it was observed to have potent wound-healing and skin-regenerating properties
Though not common, some side effects of these medications can be severe
This combined effort improves overall health and reduces the risk of weight-related conditions